Genetic and epigenetic insights into uveal melanoma

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Clinical Genetics

• Publication date

  2018-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/cge.13136PMID 28902406
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ovarian metastasis from uveal melanoma with MLH1/PMS2 protein loss in a patient with germline MLH1 mutated Lynch syndrome: consequence or coincidence?

  2017cited by this paper
• Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma

  2017cited by this paper
• Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment

  2017cited by this paper
• New concepts in the molecular understanding of uveal melanoma

  2017cited by this paper
• Uveal melanoma: relatively rare but deadly cancer

  2017cited by this paper
• Comprehensive Genetic Landscape of Uveal Melanoma by Whole-Genome Sequencing.

  2016cited by this paper
• Clinical Performance and Management Outcomes with the DecisionDx-UM Gene Expression Profile Test in a Prospective Multicenter Study

  2016cited by this paper
• Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases

  2016cited by this paper
• Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma

  2016cited by this paper
• PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma

  2016cited by this paper
• Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes.

  2016cited by this paper
• Comparing the Prognostic Value of BAP1 Mutation Pattern, Chromosome 3 Status, and BAP1 Immunohistochemistry in Uveal Melanoma

  2016cited by this paper
• Long noncoding RNA MALAT1 promotes uveal melanoma cell growth and invasion by silencing of miR-140.

  2016cited by this paper
• Class III-specific HDAC inhibitor Tenovin-6 induces apoptosis, suppresses migration and eliminates cancer stem cells in uveal melanoma

  2016cited by this paper
• A Subset of Nuclear Receptors are Uniquely Expressed in Uveal Melanoma Cells

  2015cited by this paper
• Skewed expression of the genes encoding epigenetic modifiers in high-risk uveal melanoma.

  2015cited by this paper
• BAP1 regulates cell cycle progression through E2F1 target genes and mediates transcriptional silencing via H2A monoubiquitination in uveal melanoma cells.

  2015cited by this paper
• Ruthenium-106 plaque brachytherapy for uveal melanoma

  2015cited by this paper
• Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4

  2015cited by this paper
• Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations

  2014cited by this paper
• MicroRNA expression analysis and Multiplex ligation‐dependent probe amplification in metastatic and non‐metastatic uveal melanoma

  2014cited by this paper
• Translational The Demethylating Agent 5-Aza Reduces the Growth , Invasiveness , and Clonogenicity of Uveal and Cutaneous Melanoma

  2014cited by this paper
• Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations.

  2014cited by this paper
• Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry.

  2014cited by this paper
• Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125

  2014cited by this paper
• Recent developments in prognostic and predictive testing in uveal melanoma

  2014cited by this paper
• Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP.

  2014cited by this paper
• Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma

  2014cited by this paper
• Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease.

  2014cited by this paper
• Single nucleotide polymorphism array analysis of uveal melanomas reveals that amplification of CNKSR3 is correlated with improved patient survival.

  2013cited by this paper
• TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours

  2013cited by this paper
• Influence of Age on Prognosis of Young Patients with Uveal Melanoma: A Matched Retrospective Cohort Study

  2013cited by this paper
• Impact of DNA methyltransferases on the epigenetic regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in malignant melanoma.

  2013cited by this paper
• Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3

  2013cited by this paper
• Substantial expression of luteinizing hormone-releasing hormone (LHRH) receptor type I in human uveal melanoma

  2013cited by this paper
• Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma

  2013cited by this paper
• The DecisionDx-UM Gene Expression Profile Test Provides Risk Stratification and Individualized Patient Care in Uveal Melanoma

  2013cited by this paper
• MicroRNA-9 suppresses uveal melanoma cell migration and invasion through the NF-κB1 pathway.

  2012cited by this paper
• STRING v9.1: protein-protein interaction networks, with increased coverage and integration

  2012cited by this paper
• MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets

  2012cited by this paper
• Multiplex ligation-dependent probe amplification equals fluorescence in-situ hybridization for the identification of patients at risk for metastatic disease in uveal melanoma

  2012cited by this paper
• Prevalence of ocular and oculodermal melanocytosis in Spanish population with uveal melanoma

  2012cited by this paper
• The Protein Kinase C Inhibitor Enzastaurin Exhibits Antitumor Activity against Uveal Melanoma

  2012cited by this paper
• Role of MicroRNA-182 in Posterior Uveal Melanoma: Regulation of Tumor Development through MITF, BCL2 and Cyclin D2

  2012cited by this paper
• Differential expression of fourteen proteins between uveal melanoma from patients who subsequently developed distant metastases versus those who did Not.

  2012cited by this paper
• Chromosome 3 status in uveal melanoma: a comparison of fluorescence in situ hybridization and single-nucleotide polymorphism array.

  2012cited by this paper
• Different subsets of tumor-infiltrating lymphocytes correlate with macrophage influx and monosomy 3 in uveal melanoma.

  2012cited by this paper
• Uveal melanoma cell lines contain stem-like cells that self-renew, produce differentiated progeny, and survive chemotherapy.

  2011cited by this paper
• Receiver operating characteristic analysis: calculation for the marker ‘melanoma inhibitory activity’ in metastatic uveal melanoma patients

  2011cited by this paper
• EFS shows biallelic methylation in uveal melanoma with poor prognosis as well as tissue-specific methylation

  2011cited by this paper
• Role of macrophages in uveal melanoma

  2011cited by this paper
• The miRNA expression profile of the uveal melanoma

  2011cited by this paper
• Uveal melanoma: trends in incidence, treatment, and survival.

  2011influential reference
• Frequency, molecular pathology and potential clinical significance of partial chromosome 3 aberrations in uveal melanoma

  2011cited by this paper
• Histone Deacetylase Inhibitors Induce Growth Arrest and Differentiation in Uveal Melanoma

  2011cited by this paper
• High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patients.

  2011cited by this paper
• Expression of Receptors for Luteinizing Hormone-Releasing Hormone (LH-RH) in Prostate Cancers following Therapy with LH-RH Agonists

  2010cited by this paper
• Correlation of clinicopathological parameters with HGF, c-Met, EGFR, and IGF-1R expression in uveal melanoma

  2010cited by this paper
• Methylation of PTEN as a prognostic factor in malignant melanoma of the skin.

  2010cited by this paper
• Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas

  2010cited by this paper
• Evaluation of the mTOR pathway in ocular (uvea and conjunctiva) melanoma

  2010cited by this paper
• Proteomics of uveal melanomas suggests HSP-27 as a possible surrogate marker of chromosome 3 loss.

  2010cited by this paper
• Mutations in GNA11 in uveal melanoma.

  2010cited by this paper
• Tyrosinase mRNA levels in the blood of uveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression

  2010cited by this paper
• Clinical Cancer esearch cer Therapy : Clinical ression of Receptors for Luteinizing Hormone-Releasing mone ( LH-RH ) in Prostate Cancers following Therapy R LH-RH Agonists

  2010cited by this paper
• MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.

  2009cited by this paper
• c-KIT in uveal melanoma: big fish or red herring?

  2009cited by this paper
• The association of cutaneous and iris nevi with uveal melanoma: a meta-analysis.

  2009cited by this paper
• Analysis of chromosomal aberration (1, 3, and 8) and association of microRNAs in uveal melanoma

  2009cited by this paper
• Genistein inhibits growth of human uveal melanoma cells and affects microRNA-27a and target gene expression.

  2009cited by this paper
• Survival in patients with uveal melanoma in Europe.

  2008cited by this paper
• Integrative Genomic Analysis of Aneuploidy in Uveal Melanoma

  2008cited by this paper
• Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling

  2008cited by this paper
• Frequent somatic mutations of GNAQ in uveal melanoma and blue nevi

  2008cited by this paper
• Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling

  2008cited by this paper
• Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.

  2008cited by this paper
• Oral picropodophyllin (PPP) is well tolerated in vivo and inhibits IGF-1R expression and growth of uveal melanoma.

  2008cited by this paper
• Methylation of CpG island promoters in uveal melanoma

  2008cited by this paper
• O-Mel-Inib: A Cancéro-pôle Nord-Ouest multicenter phase II trial of high-dose Imatinib mesylate in metastatic uveal melanoma

  2008cited by this paper
• Quality of evidence about effectiveness of treatments for metastatic uveal melanoma.

  2008cited by this paper
• Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma.

  2008cited by this paper
• A Metastasis Modifier Locus on Human Chromosome 8p in Uveal Melanoma Identified by Integrative Genomic Analysis

  2008cited by this paper
• Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis

  2008cited by this paper
• Targeted therapy for uveal melanoma.

  2008cited by this paper
• Emerging insights into the molecular pathogenesis of uveal melanoma.

  2008cited by this paper
• Expression of APITD1 is not related to copy number changes of chromosomal region 1p36 or the prognosis of uveal melanoma.

  2007cited by this paper
• A Role for EZH2 in Silencing of IFN-γ Inducible MHC2TA Transcription in Uveal Melanoma1

  2007cited by this paper
• Promoter methylation status of multiple genes in uveal melanoma.

  2007cited by this paper
• Biomarker discovery from uveal melanoma secretomes: identification of gp100 and cathepsin D in patient serum.

  2007cited by this paper
• Expression of Wnt5a and its downstream effector &bgr;-catenin in uveal melanoma

  2007cited by this paper
• Loss of Heterozygosity of Chromosome 3 Detected with Single Nucleotide Polymorphisms Is Superior to Monosomy 3 for Predicting Metastasis in Uveal Melanoma

  2007cited by this paper
• Serum markers to detect metastatic uveal melanoma.

  2007cited by this paper
• A role for EZH2 in silencing of IFN-gamma inducible MHC2TA transcription in uveal melanoma.

  2007cited by this paper
• Epigenetic inactivation of RASSF1a in uveal melanoma.

  2007cited by this paper
• High frequency of submicroscopic hemizygous deletion is a major mechanism of loss of expression of PTEN in uveal melanoma.

  2006cited by this paper
• Multiple locations on chromosome 3 are the targets of specific deletions in uveal melanoma

  2006cited by this paper
• Epigenetic silencing of the PTEN gene in melanoma.

  2006cited by this paper
• STRING 7—recent developments in the integration and prediction of protein interactions

  2006cited by this paper
• Epigenetic silencing of novel tumor suppressors in malignant melanoma.

  2006cited by this paper
• The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG‐1 metastasis markers and leads to the identification of DJ‐1 as a potential serum biomarker

  2006cited by this paper

• Exploring recent advances in signaling pathways and hallmarks of uveal melanoma: a comprehensive review

  2025cites this paper
• Mass Spectrometry-Based Profiling of Histone Post-Translational Modifications in Uveal Melanoma Tissues, Human Melanocytes, and Uveal Melanoma Cell Lines – A Pilot Study

  2024cites this paper
• GNAQ/GNA11-Related Benign and Malignant Entities—A Common Histoembriologic Origin or a Tissue-Dependent Coincidence

  2024cites this paper
• Genome-Wide Methylation Patterns in Primary Uveal Melanoma: Development of MethylSig-UM, an Epigenomic Prognostic Signature to Improve Patient Stratification

  2024cites this paper
• Current therapeutic strategies for the treatment of ocular melanoma

  2024cites this paper
• PRKC Fusion Melanocytic Tumors, a Subgroup of Melanocytic Tumors More Closely Aligned to Blue Nevi Than to PRKAR1A-inactivated Pigmented Epithelioid Melanocytomas

  2024cites this paper
• Recent approaches for the treatment of uveal melanoma: Opportunities and challenges.

  2023cites this paper
• Tumor subtypes and signature model construction based on chromatin regulators for better prediction of prognosis in uveal melanoma

  2023cites this paper
• Inhibiting the growth of melanoma cells via hTERT gene editing using CRISPR-dCas9-dnmt3a system.

  2022cites this paper
• N6-Methyladenosine-Modification-Related Ophthalmic Diseases and Potential Therapeutic Strategies.

  2022cites this paper
• NSUN2-mediated RNA m5C modification modulates uveal melanoma cell proliferation and migration

  2022cites this paper
• GNAQ and GNA11 Genes: A Comprehensive Review on Oncogenesis, Prognosis and Therapeutic Opportunities in Uveal Melanoma

  2022cites this paper
• Genetic determinants of lung cancer: Understanding the oncogenic potential of somatic missense mutations.

  2022cites this paper
• Liver metastasis in uveal melanoma - treatment options and clinical outcome.

  2022cites this paper
• Potential of miRNA-Based Nanotherapeutics for Uveal Melanoma

  2021cites this paper
• In-vivo imaging for assessing tumor growth in mouse models of ocular melanoma.

  2021cites this paper
• Epigenetic Regulatory Enzymes: mutation Prevalence and Coexistence in Cancers

  2021cites this paper
• ALKBH5-mediated m6A demethylation of FOXM1 mRNA promotes progression of uveal melanoma

  2021cites this paper
• Correction to: The long non-coding RNA SAMMSON is essential for uveal melanoma cell survival

  2021cites this paper
• Current molecular and clinical insights into uveal melanoma (Review)

  2021cites this paper
• PPAR-Responsive Elements Enriched with Alu Repeats May Contribute to Distinctive PPARγ–DNMT1 Interactions in the Genome

  2021cites this paper
• The long non-coding RNA SAMMSON is essential for uveal melanoma cell survival

  2021cites this paper
• X-Linked Tumor Suppressor Genes Act as Presumed Contributors in the Sex Chromosome-Autosome Crosstalk in Cancers

  2021cites this paper
• mTOR Inhibition Enhances Delivery and Activity of Antisense Oligonucleotides in Uveal Melanoma Cells

  2021cites this paper
• Targeting Epigenetic Modifications in UM

  2020cites this paper
• Does epigenetics have a role in age related macular degeneration and diabetic retinopathy?

  2020cites this paper
• Targeting Epigenetic Modifications in Uveal Melanoma

  2020cites this paper
• Identification of histone deacetylase inhibitors with (arylidene)aminoxy scaffold active in uveal melanoma cell lines

  2020cites this paper
• Iris Colour and the Risk of Developing Uveal Melanoma

  2020cites this paper
• DNA Methylation and Bladder Cancer: Where Genotype does not Predict Phenotype

  2020cites this paper
• Immunotherapy for uveal melanoma - Current knowledge and perspectives.

  2020cites this paper
• RNA m6A methylation regulates uveal melanoma cell proliferation, migration, and invasion by targeting c‐Met

  2020cites this paper
• Genome organization in proximity to the BAP1 locus appears to play a pivotal role in a variety of cancers

  2020cites this paper
• Targeted Therapy of Uveal Melanoma: Recent Failures and New Perspectives

  2019cites this paper
• Spatial intratumor heterogeneity in uveal melanoma: Tumor cell subtypes with a presumed invasive potential exhibit a particular epigenetic staining reaction

  2019cites this paper
• Basal cell carcinomas developing independently from BAP1‐tumor predisposition syndrome in a patient with bilateral uveal melanoma

  2019cites this paper
• Uveal Melanoma: an Updated Review

  2019influential citation
• m6A modification suppresses ocular melanoma through modulating HINT2 mRNA translation

  2019cites this paper
• Mutational Landscape of the BAP1 Locus Reveals an Intrinsic Control to Regulate the miRNA Network and the Binding of Protein Complexes in Uveal Melanoma

  2019cites this paper
• Uveal Melanoma: Molecular Pathology

  2019cites this paper
• PARP Inhibition Increases the Response to Chemotherapy in Uveal Melanoma

  2019cites this paper
• MiR-216a-5p/Hexokinase 2 axis regulates uveal melanoma growth through modulation of Warburg effect.

  2018cites this paper
• Epigenetics, microbiota, and intraocular inflammation: New paradigms of immune regulation in the eye.

  2018cites this paper
• Corrigendum

  1987cites this paper